Table 2.
Validation parameters of the method for the studied analytes in rat plasma.
| Parameter | Hydroxychloroquine | Favipiravir | Oseltamivir | Remdesivir |
|---|---|---|---|---|
| Linear range (ng/mL) | 5–100 | 50–1000 | 5–100 | 10–100 |
| Mean ± Standard deviation (S.D) | 99.75 ± 0.75 | 98.01 ± 1.41 | 99.63 ± 1.31 | 100.04 ± 1.67 |
| R.S.D* | 0.75 | 0.14 | 1.31 | 1.67 |
| Regression Equation | Y = 0.0277 X -0.0079 | Y = 0.0003X + 0.021 | Y = 0.0235X + 0.1993 | Y = 0.0197X ± 0.1648 |
| Correlation Coefficient (r) | 0.9999 | 0.9998 | 0.9999 | 0.9999 |
| Intraday precision (%R.S.D) | 0.83 | 0.47 | 2.30 | 1.10 |
| Interday Precision (%R.S.D) | 0.60 | 0.85 | 0.52 | 0.55 |
| Limit of Detection (L.O.D)** (ng/mL) | 0.11 | 10.00 | 0.92 | 1.71 |
| Limit of Quantitation (L.O.Q)*** (ng/mL) | 0.36 | 33.33 | 3.07 | 5.72 |
LOD and LOQ are determined based on signal to noise ratio.
RSD*: relative standard deviation before
LOD** =3 × S/N.
LOQ***=10 × S/N.